Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05477784 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotableResults posted: Sep 22, 2026Primary endpoints revised (5) · Interventions: Educational Intervention (Other), Informational Intervention (Other), Questionnaire Administration (Other) to Group 1: Educational counseling intervention (Behavioral), Group II Active Comparator (Behavioral) · Eligibility criteria expanded, about 9 words · 3 moreShow 6 more changesShow less
Primary endpoints revised (5)
Interventions: Educational Intervention (Other), Informational Intervention (Other), Questionnaire Administration (Other) to Group 1: Educational counseling intervention (Behavioral), Group II Active Comparator (Behavioral)
Eligibility criteria expanded, about 9 words
Secondary endpoints shortened, about 18 words
Study description expanded, about 80 words
Site details revised at 1 of 2 sites
NotablePrimary endpoints: 6 to 5Sponsor's reason: Study terminated due to insufficient funding. to Enrollment rates to the trial were lower than projected and anticipated. · Primary completion date: May 27, 2025 to May 21, 2025 · Completion date: May 27, 2025 to Aug 15, 2025 · 1 morev15Show 4 more changesShow less
Sponsor's reason: Study terminated due to insufficient funding. to Enrollment rates to the trial were lower than projected and anticipated.
Primary completion date: May 27, 2025 to May 21, 2025
StoppedTrial status: Recruiting to TerminatedSponsor's reason: Study terminated due to insufficient funding.Enrollment target: estimated 1590 to confirmed 174 · Primary completion date changed from estimate of Jan 31, 2026 to May 27, 2025 · Study completion date changed from estimate of Jul 31, 2026 to May 27, 2025 · 1 morev14Show 4 more changesShow less
Enrollment target: estimated 1590 to confirmed 174
Primary completion date changed from estimate of Jan 31, 2026 to May 27, 2025
Study completion date changed from estimate of Jul 31, 2026 to May 27, 2025
Site details revised at 2 of 2 sites
MinorSite contacts updated at 1 of 2 sitesv13
MinorRe-verified, no change to tracked fieldsv12
Show 10 earlier versionsHide 10 earlier versions
MinorStudy sites: 5 to 2v11
MinorSite contacts updated at 1 of 5 sitesv10
Minor2 versionsRe-verified since May 23, 2023, no change to tracked fieldsv8-v9
NotableStart date: Apr 1, 2022 to Jul 19, 2022v7
MinorCompletion date: Jan 31, 2026 to Jul 31, 2026v6
NotablePrimary completion date: Jan 31, 2027 to Jan 31, 2026Completion date: Mar 31, 2027 to Jan 31, 2026v5Show 1 more changeShow less
Completion date: Mar 31, 2027 to Jan 31, 2026
NotableEnrollment target: 795 to 1590Study sites: 1 to 5v4Show 1 more changeShow less
Study sites: 1 to 5
MinorRe-verified, no change to tracked fieldsv3
NotablePrimary endpoints revised (6)Interventions: Control group (Behavioral), Enhancing Connections Program (Behavioral) to Educational Intervention (Other), Informational Intervention (Other), Questionnaire Administration (Other) · Eligibility criteria expanded, about 24 words · Secondary endpoints expanded, about 106 words · 3 morev2Show 6 more changesShow less
Interventions: Control group (Behavioral), Enhancing Connections Program (Behavioral) to Educational Intervention (Other), Informational Intervention (Other), Questionnaire Administration (Other)
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial examines the usefulness of two educational programs for parents with late-stage cancer who have a 5 - 17 year old child. The programs are designed to enhance the quality of the parent-child relationship and add to the parent's confidence in managing the impact of their cancer on their child. Educational programs may reduce anxiety and depression and improve the well-being and quality of life of parents with advanced cancers and their children.
Recruitment occurs nationally via referral to the Fred Hutch/University of Washington Cancer Consortium team.